Document is current
Any future updates will be listed below
-
Authors
Lawlor, Peter G. http://orcid.org/0000-0001-7319-1395
McNamara-Kilian, Marie T.
MacDonald, Alistair R.
Momoli, Franco
Tierney, Sallyanne
Lacaze-Masmonteil, Nathalie
Dasgupta, Monidipa
Agar, Meera
Pereira, Jose L.
Currow, David C.
Bush, Shirley H.
-
Funding
Funding for this research was provided by:
Department of Medicine, Ottawa Hospital
- License Information
-
More Information
Article History
Received: 28 July 2020
Accepted: 7 October 2020
First Online: 21 October 2020
Ethics approval and consent to participate
: The Bruyère Continuing Care Research Ethics Board (Approval number M16–13-042) and the Ottawa Health Science Network Research Ethics Board (Approval number 20130639-01H) have approved the study design, protocol and informed consent procedures. The trial was approved by Health Canada (regulatory). (Health Canada protocol number BRI-MELAT-2013). This study was performed in compliance with the Canadian Tri-Council Policy Statement version 2 (TCPS 2), the Natural Health Products Regulations Part 4, the Personal Health Information Protection Act (PHIPA) of Ontario, Canada, and the ICH GCP. Prior to study enrollment, informed written consent was obtained for all study participants from either participants or their SDM if the participant were cognitively impaired and lacked capacity to make healthcare decisions.
: Not applicable.
: The authors declare that they have no competing interests.
